A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive response differ.

Link as first comment.

#longevity #geroscience #lecanemab #amyloid #bloodproteins

#AskDrMia is sharing tips you may not know when considering infusion medications like #Lecanemab #Donanemab #Leqembi #Kisnula for #dementia. Stream the whole episode wherever you stream your #Podcasts.
youtube.com/shorts/j4D-I...

Ever wonder what advice a #geriatrician would give their own family about about infusion medications like #lecanemab #donanemab #leqembi #kisunla for #dementia? #AskDrMia gives her audience the family treatment in this new episode. Stream wherever you listen to podcasts
youtube.com/shorts/WSUOa...

This week, the “Ask” in #AskDrMia shines as @askdrmia.bsky.social breaks down new research in anti-amyloid treatments. What #caregivers should know and more wherever you listen to #podcasts. #lecanemab #Leqembi #donanemab #Kisunla #amyloids #dementia #memory
youtube.com/shorts/hA1K8...

Study Reveals Plasma p-Tau217 as a Tracker for Lecanemab Response in Early Alzheimer's #South_Korea #Seoul #Korea_University #Lecanemab #p-Tau217